Drug intelligence / Profile preview

KOEN E250 TZ

Development stage: Unknown
Lead developer: Nippon Zenyaku Kogyo
Modality: Small Molecules
Administration: Oral

Overview

KOEN E250 TZ is a veterinary mineral salt block (lick block) developed and marketed by Nippon Zenyaku Kogyo (ZENOAQ) for ruminants, particularly cattle. Classified as a pharmaceutical in Japan, it is part of the KOEN series, which is a leading brand of mineral blocks in the Japanese market. The E250 TZ formulation is specifically enriched with selenium and vitamin E to address and prevent nutritional deficiencies that can lead to conditions like white muscle disease (nutritional muscular dystrophy). The product is designed for outdoor use, featuring high palatability, durability, and water resistance to ensure consistent nutrient intake through licking.

Brand names: KOEN E250 TZKOEN
Other names: KOEN E250 TZ mineral salt block

Targets

GPX4 (Glutathione peroxidase 4)

Beyond the preview

Go deeper on KOEN E250 TZ.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KOEN E250 TZ.

Explore the full profile